The mark consists of LUMAKRAS with half circle design over KRAS.
Mark For: LUMAKRAS® trademark registration is intended to cover the categories of pharmaceutical preparations for use in the prevention of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations for use in the treatment of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders. [all]
>The mark consists of "LUMAKRAS" with half circle design over "KRAS".
Status
2021-04-02 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
Yes
Filed ITU
Yes
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Attorney Name
Elsa D. Lemoine
Attorney Docket Number
TM-2135-US-1
Timeline
2021-02-17
Application Filed
2021-02-20
Location: NEW APPLICATION PROCESSING
2021-02-20
Status: Live/Pending
2021-02-20
Status: New application will be assigned to an examining attorney approximately 3 months after filing date.
ELSA D. LEMOINE AMGEN INC. ONE AMGEN CENTER DRIVE TRADEMARK OPERATIONS-MS-28-5A THOUSAND OAKS, CA 91320-1799
Good, Services, and Codes
IC 044. US 100 101. G & S: medical information services, namely, providing information regarding oncological diseases and disorders; online information services, namely, providing information regarding oncological diseases and disorders via a global computer network. FIRST USE: 20210603. FIRST USE IN COMMERCE: 20210603
International Codes:
5
U.S. Codes:
005,006,018,044,046,051,052
International Codes:
44
U.S. Codes:
100,101
Type Code
Type
DM0000
The mark consists of LUMAKRAS with half circle design over KRAS.
DM0000
The mark consists of "LUMAKRAS" with half circle design over "KRAS".
Trademark Filing History
Description
Date
Proceeding Number
REGISTERED-PRINCIPAL REGISTER
2022-05-03
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2022-03-30
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2022-03-29
STATEMENT OF USE PROCESSING COMPLETE
2022-02-23
71906
CASE ASSIGNED TO INTENT TO USE PARALEGAL
2022-02-18
71906
USE AMENDMENT FILED
2022-01-31
71906
TEAS STATEMENT OF USE RECEIVED
2022-01-31
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2021-12-21
PUBLISHED FOR OPPOSITION
2021-10-26
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2021-10-26
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2021-10-06
APPROVED FOR PUB - PRINCIPAL REGISTER
2021-09-16
TEAS VOLUNTARY AMENDMENT RECEIVED
2021-09-15
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
2021-09-15
88889
ASSIGNED TO EXAMINER
2021-09-13
76833
NOTICE OF DESIGN SEARCH CODE E-MAILED
2021-05-20
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.